ClinicalTrials HQ

Vanda Pharmaceuticals

Vanda Pharmaceuticals

Explore linked clinical trials.

19 results · Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsSchizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizophreniaRecruitingPhase 42026-10-01NCT05648591
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-09-24NCT06830044
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque PsoriasisSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorderRecruitingPhase 32026-09-22NCT07362017
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual PatientCharcot-Marie-Tooth disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, central nervous system malformation, hereditary disease, hereditary motor and sensory neuropathy, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathyActive, not recruitingPhase 1 / Phase 22026-08-19NCT07223632
Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative ColitisDigestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitisRecruitingPhase 32026-08-18NCT07686081
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorderanxiety disorder, phobic disorder, psychiatric disorder, social phobiaActive, not recruitingPhase 32026-08-17NCT07221578
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric InsomniaDyssomnias, Sleep Disorders, Intrinsic, Sleeplessness, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 32026-06-05NCT06953869
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist UseBody Weight, Nausea, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting, nutritional disorder, obesity disorder, overnutritionRecruitingPhase 32026-04-20NCT07446439
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion SicknessPathological Conditions, Signs and Symptoms, Signs and Symptoms, motion sicknessActive, not recruitingPhase 32026-04-16NCT06138613
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic MalignanciesDisease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasmRecruitingPhase 12026-03-16NCT03838926
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertensioncardiovascular disorder, hypertensive disorder, vascular disorderRecruitingPhase 22026-02-27NCT07090161
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe OnychomycosisBacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, dermatomycosis, fungal infectious disease, nail disorder, skin disorder, skin disorder caused by infection, tinea infection, tinea unguiumActive, not recruitingPhase 22026-02-04NCT07065773
Randomized Withdrawal Study in Patients With SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 32026-01-12NCT06961968
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eyedry eye syndrome, eye disorder, lacrimal apparatus disorderRecruitingPhase 22025-09-17NCT07179055
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic GastroparesisDigestive System Diseases, Nausea, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting, digestive system disorder, gastroparesis, idiopathic gastroparesis, palsy, stomach disorderRecruitingPhase 32025-02-20NCT06836557
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 VariantChronobiology Disorders, Dyssomnias, Neurologic Manifestations, Occupational Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, circadian rhythm sleep disorder, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 32024-11-22NCT06701396
Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep DisturbancesSleep Disturbances in Smith-Magenis SyndromeRecruitingNot stated2024-03-20NCT03154697
Patient Registry of Blind Subjects With Sleep-related ProblemsNeurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), eye disorder, nervous system disorder, vision disorderRecruitingNot stated2020-06-24NCT01195558
ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 InfectionCoronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, viral infectious diseaseEnrolling by invitationPhase 32020-04-20NCT04326426